Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jul 2;14(7):670.
doi: 10.3390/antibiotics14070670.

Extraintestinal Manifestations of Clostridioides difficile Infections: An Overview

Affiliations
Review

Extraintestinal Manifestations of Clostridioides difficile Infections: An Overview

Konstantinos Mpakogiannis et al. Antibiotics (Basel). .

Abstract

Introduction: Clostridioides difficile (C. difficile) is primarily associated with colonic disease, including pseudomembranous colitis. However, in rare instances, it may cause extraintestinal infectious and non-infectious manifestations, particularly in immunocompromised patients or those with significant underlying conditions.

Search methods: A literature review was performed using PubMed, Embase, and Researchgate databases up to 15 February 2025. The following search strings were used: "extraintestinal manifestations", "extracolonic manifestations", "extraintestinal infections", "extracolonic infections", "Clostridium difficile", and "Clostridioides difficile".

Results: Extraintestinal manifestations of C. difficile appear to represent fewer than 1% of all reported infections. The most frequently reported infectious complications include bacteremia and abdominopelvic infections and abscesses, often involving polymicrobial cultures, with the isolation of C. difficile alongside microorganisms typically found in the normal intestinal microbiota. Rare non-infectious cases, such as reactive arthritis, have also been described. The underlying pathogenetic mechanism is believed to involve disruption of the intestinal barrier and translocation of bacteria or toxins to sterile sites.

Conclusions: Though rare, extraintestinal C. difficile manifestations pose important clinical challenges. Better understanding of their mechanisms is essential for early recognition and appropriate management. Further research is warranted to define potential mechanisms and therapeutic approaches.

Keywords: Clostridioides difficile; Clostridium difficile; extraintestinal infections; extraintestinal manifestations.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Similar articles

References

    1. Vedantam G., Clark A., Chu M., McQuade R., Mallozzi M., Viswanathan V.K. Clostridium difficile Infection. Gut Microbes. 2012;3:121–134. doi: 10.4161/gmic.19399. - DOI - PMC - PubMed
    1. Hall I.C. Intestinal flora in New-Born infants. Am. J. Dis. Child. 1935;49:390. doi: 10.1001/archpedi.1935.01970020105010. - DOI
    1. Markovska R., Dimitrov G., Gergova R., Boyanova L. Clostridioides difficile, a New “Superbug”. Microorganisms. 2023;11:845. doi: 10.3390/microorganisms11040845. - DOI - PMC - PubMed
    1. Tedesco F.J., Barton R.W., Alpers D.H. Clindamycin-Associated Colitis. Ann. Intern. Med. 1974;81:429–433. doi: 10.7326/0003-4819-81-4-429. - DOI - PubMed
    1. Brown K.A., Khanafer N., Daneman N., Fisman D.N. Meta-Analysis of Antibiotics and the Risk of Community-Associated Clostridium difficile Infection. Antimicrob. Agents Chemother. 2013;57:2326–2332. doi: 10.1128/AAC.02176-12. - DOI - PMC - PubMed

LinkOut - more resources